chapter 7 comparative study of the properties and...
TRANSCRIPT
Chapter 7
Comparative study of the properties and applications of chitosan-g-polymers
Scope of the Chapter
In this chapter, a comparative study of all the chitosan-g-vinyl polymers is given.
The DSC and XRD studies are compared to reveal the crystalline/amorphous nature and
the thermograms to foretell the thermal stability as an index of extent of grafting. The
swelling index and under-water octane contact angles are measured to determine the
hydrophilicity and the tensile stress and elongation at break, to evaluate the mechanical
stability of the copolymers. The haemolysis induced by the copolymers to the blood
samples, the cytotoxicity test on L929 cells by MTT assay and live-dead assay, the mass-
loss and tensile stress-loss of the copolymer films due to enzymatic degradation etc are
compared. The low molecular weight solute permeability of the films are compared to
choose the best film synthesized, to be proposed as a haemodialysis membrane which has
a performance equal to or better than commercial cellulose films.
Chapter Chapter Chapter Chapter 7777
230
7.1. Background
This chapter deals with the comparative study of the polymers in terms of their
physico-chemical properties, biocompatibilities and their possible biomedical
applications. As chitosan modified with HEMA, PEGm and PVAC/PVOH were
evaluated for possible haemodialysis applications, a comparative study of their
permeation properties has also been made. Though chitosan-g-PMMA could not be
processed into films for evaluation as membranes for haemodialysis applications, it could
be processed into porous microspheres and evaluated for drug release applications.
7.2. Comparison of Physico-Chemical Properties
All the copolymers were synthesized by the same technique by a redox initiated
free radical route using ceric ammonium nitrate as the redox initiator. The products were
purified by precipitation using aqueous sodium hydroxide solution, washing extensively
with water and drying. The copolymers were soxhelet-extracted with a suitable solvent to
remove the homopolymer formed during the reaction process. The purified copolymers
were dissolved in aqueous acetic acid solution and films were cast by evaporating the
solvent. The copolymers were characterized by various physico-chemical
characterization techniques and a comparative study of the properties of the different
copolymers was carried out.
FTIR spectroscopy was found to be very useful for the confirmation of the
grafting reaction between chitosan and the vinyl monomers. The presence of the -C=O
stretching vibrations of the carbonyl group of the vinyl polymers at around 1730-1740 cm-1 in
the copolymer spectra, was used for the identification of the pendant vinyl graft. In all
the copolymer spectra the intensity of this peak increased as the amount of monomer in
the graft segment increased. The characteristic peaks of chitosan, the Amide I and Amide II
bands at around 1642 and 1580 cm-1 respectively and the symmetric stretching vibrations
of the -NH2/-OH groups at 3443 cm-1 are distinctly visible in the copolymer spectra.
Chapter Chapter Chapter Chapter 7777
231
The thermal properties of the copolymers were studied using the techniques like
DSC, TGA, and DTG. The DSC was used to get the glass transition temperature of the
copolymers. Poly(HEMA) and PMMA when grafted onto chitosan the copolymers gave
a Tg at around 111ºC, and 120ºC respectively, while chitosan-g-PVAc copolymers
exhibited a glass transition temperature at 28-29ºC and chitosan-g-PVOH at 36-40ºC
which is well below the glass transition temperature of virgin chitosan. Chitosan-g-
PEGm copolymers did not show any distinct glass transition temperature, but they
manifested a clear melting endotherm of the PEO segment. As the PEO concentration
increased, these endotherms became more prominent. Hence, the glass transition
temperatures of the copolymers foretell that the chitosan-g-poly(vinyl acetate)
copolymers will be soft while the chitosan-g PMMA/PHEMA brittle at room
temperature. The chitosan-g-PEGm copolymers were predominantly of soft nature
contributed by PEG graft. The DSC studies revealed that the chitosan-g-PEGm
copolymers have a crystalline nature as the copolymers manifested a melting endotherm
without showing any significant glass transition temperature. The SEM micrographs and
XRD studies also supported this.
Though thermal stability is not of concern for the projected applications of the
polymers, these are finger prints for the molecular configuration and composition, and
thus serve as effective characteristics. The thermo gravimetric analysis (TGA) showed
that grafting with vinyl monomers did not cause any adverse effect on the thermal
stability of chitosan, on the other hand in certain cases the thermal stability is enhanced
due to grafting. Grafting with poly(HEMA) and PMMA enhanced the thermal stability
of chitosan, while grafting with PVAc and PEGm did not affect its thermal stability.
The two-stage decomposition temperature of the copolymers compared to the
single stage decomposition temperature of virgin chitosan confirms the grafting reaction
between chitosan and the vinyl monomer. This is further confirmed from the DTG of the
copolymers which gave an additional peak due to the decomposition of the pendant vinyl graft.
Chapter Chapter Chapter Chapter 7777
232
The crystalline structure of chitosan is lost due to grafting with vinyl monomers
as evident from the X-ray diffraction pattern of chitosan and the copolymers. The
amorphous PHEMA, PMMA and PVAc when grafted on to chitosan, the crystalline peak
intensity of chitosan (2 θ= 20º) decreased. In the case of chitosan grafted with PEGm, the
graft polymer manifested additional diffraction pattern at 2θ = 40º and 70º due to the
pendant comblike graft of PEO, where PEO forms crystallites.
The mechanical property evaluation revealed that grafting with poly(HEMA) led
to rigidification of the graft copolymer by way of strong intermolecular H-bonding.
Under wet conditions, the copolymers showed a further decrease in property. PMMA
grafting also caused an enormous decrease in the tensile strength of chitosan under wet
condition. The elongation also decreased. The mechanical property of the films in the dry
condition was not studied as the films were weak and fragile. The grafting of PVAc
resulted in an enormous increase in the tensile strength of chitosan film both in the dry
and wet states. Though there was not much change in elongation under dry state, it
increased considerably under wet condition as the vinyl acetate segments are more soft
and extensible. On the otherhand, the grafting with PEGm resulted only in a marginal
increase in the tensile strength of chitosan film in the dry state. But a moderate grafting
helped improve the tensile strength of the copolymer films. However, under wet
conditions, grafted polymers showed a decrease in tensile strength.
It can be noted that certain compositions of chitosan-g-poly(vinyl acetate) and
chitosan-g-poly(vinyl alcohol) films achieved the highest tensile strength in the dry
condition, (123 MPa for the former and 136 MPa for the latter, the value for virgin
chitosan in the same conditions being 35 MPa). Chitosan-g-PEGm films gained 46 MPa.
In the case of chitosan-g-PMMA films the tensile property of the dry films could not be
evaluated at all due to its brittle nature. The maximum wet strength of the chitosan-g-
PHEMA films is 18 MPa and chitosan-g-PEGm films is 11 MPa. The chitosan-g-PVAc
films exhibited the maximum wet strength of 59 MPa and chitosan-g-PVOH films,
63MPa. Thus, the copolymers of chitosan with poly(HEMA), PVAc, PVOH and PEGm possess
Chapter Chapter Chapter Chapter 7777
233
the required strength to be proposed for any type of membrane applications. The mechanical
property data of the different copolymers compared to chitosan films are given in Table 7.1.
Table7.1. The maximum achieved tensile properties of the copolymer films in
comparison to chitosan films
Tensile strength (MPa) % Elongation Films
Grafting (wt %) Dry Wet Dry Wet
CH-0 0 35+ 11 51+7 15 ± 7 92 ± 7
CH-PMMA 177 - 6.7 ± 2.3 - 43 ± 4
CH-PHEMA 385 34 +8 18 + 3 2 ± 0.2 90 ± 13
CH-PVAc 92 117 + 1 59 + 10 13 ± 0.4 163 ± 8
CH-PVOH 85 82+ 23 47+ 3 23 ± 7 169 ± 12
CH-PEGm 164 45+73 6.5+ 1 9.3 ± 3 45.4 ± 1
The hydrophilicity of the copolymers was checked by the water swelling and
under water contact angle studies. Swelling studies imply that the hydrophilicity is
significantly improved by graft co-polymerisation of HEMA onto chitosan. Though
PMMA is a hydrophobic polymer, the chitosan-g-PMMA with a medium extent of
grafting was found to be more hydrophilic than virgin chitosan. Chitosan is highly
crystalline due to the strong intermolecular hydrogen bonding among the –NH2 and –OH
groups of the adjacent linear chains. Grafting with PMMA, to a certain extent, will
disrupt this strong intermolecular hydrogen bonding and facilitates hydrogen bonding
with water and leads to increased hydrophilicity of the medium-grafted copolymers. As
the PMMA content increases the organic nature of PMMA predominates conferring
hydrophobicity to the copolymer (CH-M10). On grafting the hydrophobic monomer,
vinyl acetate, chitosan is expected to increase hydrophobicity which is confirmed by the
results. In this case also, the moderate PVAc grafting is conducive to enhancing the
swelling characteristics. A dramatic increase in the swellability of chitosan-g-PEGm was
observed at pH 7.4 for the graft copolymer with 320 % grafting. The swelling % of the
PHEMA and PMMA grafted chitosan films at pH 1.98 could not be determined
accurately beyond 10 minutes, as the films started degrading at this stage. This indicated the
Chapter Chapter Chapter Chapter 7777
234
dissolution tendency of the films, as the swelling exceeded a certain level. But in the case of
chitosan-g-PVAc, the films showed higher stability in the acidic pH. The chitosan-g-PVOH
films also showed increased acid resistance when compared to virgin chitosan films.
0
100
200
300
400
500
600
CH-0 CH-HE12.5 CH-M10 CH-V10B CH-V10A CH-P7.5
Copolymer codes
% S
wel
ling
Fig 7.1. % Swelling of the copolymer films at pH 7.4 (24 h study)
The under-water octane contact angle values also supported the above findings in
all the cases (Fig 7.2).
60
80
100
120
140
160
180
200
CH-0 CH-HE12.5 CH-M10 CH-V10B CH-V10A CH-P7.5
Fig 7.2. Octane contact angle values of the copolymer films
Chapter Chapter Chapter Chapter 7777
235
Thus, the physico-chemical characterization studies concluded that the
copolymers were of variable mechanical strengths and hydrophobic/hydrophilic
characteristics. A proper choice of the appropriate vinyl monomers and adjusting the
extent of grafting and transformation of the pendant grafts (as in the case of chitosan-g-
PVAc and chitosan-g-PVOH) would be effective in the synthesis of tailor-made, natural-
synthetic hybrids for varied engineering and bio-medical applications.
7.3. Preliminary Biocompatibility Evaluation
The preliminary biocompatibility evaluation was done by studying the blood
material interaction and cytotoxic response of the chitosan copolymers. The blood
material interaction studies included, evaluating the % haemolysis, reduction in cell
counts like, WBC, RBC and platelets as an effect of the material contact with the blood.
The studies were conducted following the standard protocol, ISO 10993-4. The simplest
and the most commonly conducted blood compatibility test is the haemolysis test. Fig 7.3
illustrates the % haemolysis of the blood samples which are exposed to the copolymer
films compared with the reference (empty polystyrene dishes) material. None of the
samples induced haemolysis to the blood samples when compared to the reference.
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
CH-0
CH-HE5
CH-HE7.5
CH-HE10
CH-HE12
.5
CH-M4
CH-M10
CH-V4B
CH-V10
B
CH-V4A
CH-V10
A
CH-P5
Refer
ence
% H
aem
oly
sis
Fig 7.3. Percentage haemolysis of the copolymers
Chapter Chapter Chapter Chapter 7777
236
According to ASTM standards, ASTM F 756-00, a material with a haemolysis
value less than 2% is considered as haemocompatible. Fig 7.3 shows that all the
copolymers have a haemolysis value less than 2% (ranging from 0.25% to 0.55%) and
are suitable for blood contacting applications. As far as the cell count changes of WBC,
RBC and platelets are concerned, none of the parameters showed any significant
reduction as an effect of material contact with the blood.
The cytotoxicity evaluation was done using L929 mouse fibroblast cells. L929 is
an established and well characterized mammalian cell line that has demonstrated
reproducible results. One of the most sensitive toxicity testing protocols is based on the
direct contact of the sample with the cell culture. The test on extract study was also used
for the cytotoxicity evaluation of the microspheres. The test protocols were as per ISO
10993-5. All the copolymers were found to be highly cytocompatible proving that these
materials could be used for any of the biomedical applications.
The viability of the fibroblast cells after incubating with the materials for 48h was
assessed by a dual staining technique using a 1:1 mixture of acridine orange and
ethidium bromide as detailed in chapter 2. The live cells stain green and the dead cells
deep red when observed under the fluorescent microscope.
Chapter Chapter Chapter Chapter 7777
237
Fig 7.4a. Live-dead assay with L929 mouse fibroblast cells on contact with chitosan (1-3), chitosan-g-poly(HEMA) (4-6), chitosan-g-PEGm (7-9), chitosan-g-PVAc (9-12)
and chitosan-g-PVOH (13-15) with different magnifications (of the objective)
Fig 7.4a is the fluorescent microscopic image of the stained cells after culturing on
chitosan and the copolymer films for 48 h. All the cells on contact with the materials are
green confirming that the materials are cytocompatible to L929 mouse fibroblast cells.
The quantitative determination of the cytotoxicity of the materials was done by
MTT assay. The Fig 7.4b depicts that all the copolymer films are highly cytocompatible
showing 100% metabolically active cells when compared to the controls (cells without
materials). The percentage viability (living cells) values greater than 100% indicate the
cell proliferation. As the chitosan-g-PMMA is used for the preparation of microspheres,
Chapter Chapter Chapter Chapter 7777
238
the MTT assay was done on the microspheres to assess the cytocompatibility of them
quantitatively.
0
40
80
120
160
200
CH-0 CH-HE7.5 CH-V6B CH-V6A CH-P5 Reference
%V
iab
ility
Fig 7.4b. Cytotoxicity evaluation of chitosan copolymer films by MTT
assay using L929 mouse fibroblast cells
The biodegradability of the films was assessed by analyzing the FTIR spectra of
the films, mass-loss of the films and also from the reduction in the mechanical properties
of the films after exposure to test solutions. All the graft copolymer films were more
stable in the enzymatic environment than the virgin chitosan films. The FTIR spectra of
the films showed signs of degradation as evident by the absence or reduction in the
intensity of certain characteristic peaks. The percentage mass-loss and percentage tensile
strength-loss observed for the different copolymer films are given in Table 7.2. The
chitosan-g-PVAc and chitosan-g-PVOH films underwent the maximum mass-loss, (37
and 25%) compared to other copolymer films. Chitosan grafted with poly(HEMA),
PMMA, and PEGm displayed almost similar range of percentage mass loss, viz; 5%, 3-
5% and 5-13% respectively. The tensile properties of the copolymer films when
examined after keeping in the enzyme solution for one month showed a decrease in the
range of 35 to 93% whereas the tensile strength loss of virgin chitosan film is 91%.
Chapter Chapter Chapter Chapter 7777
239
Table 7.2. The mass-loss and tensile stress-loss of the films after keeping in enzyme solution
S.No Films Mass- loss (%) Tensile Stress-loss
(%)
1 Chitosan 25 91
2 Chitosan-g-PHEMA 5 85 to 93
3 Chitosan-g-PMMA 5 to 9 54 to 84
4 Chitosan-g-PVAc 3 to 37 56 to 81
5 Chitosan-g PVOH 4 to 25 35 to70
6 Chitosan-g-PEGm 5 to 13 Not done
Hence, it is concluded that the copolymer films, except CH-V4B and CH-V4A
retained their shape and mass in the enzyme solution more than the virgin chitosan films
but the strength of the films underwent deterioration to the same extent or less than
chitosan films.
7.4. Assessment of the Copolymers for Biomedical Applications
7.4.1. Copolymers as Haemodialysis Membranes
7.4.1.1. Background of the Study
Permeability is a measure of the clearance rate of molecules of medium molecular
weight. The artificial kidney, or dialyzer, is a life support system designed and the active
part of it is the semi permeable membrane itself, for which commercially regenerated
cellulose or cuprophan is still being used due to its good solute permeability and
mechanical strength. Since the primary action of the cellulose membrane is that of a
sieve, there is little selectivity in the separation of two closely related molecules. As
explained earlier, the membranes with desirable mechanical strength, e.g. chitosan-g-
PHEMA, chitosan-g-PVAc, chitosan-g-PVOH and chitosan-g-PEGm were explored for
their permeability to small molecular weight solutes like creatinine, urea, glucose and the
high molecular weight solute, albumin. Fig 7.5 to 7.8 show a comparative evaluation of
the maximum amount of the solutes permeated through each copolymer films (of
Chapter Chapter Chapter Chapter 7777
240
comparable thickness) for 24 h. Within 24 h, all the copolymer films and virgin chitosan
film permeated > 30% of the initial amount of creatinine present in the donor
compartment. The chitosan-g-PVAc films showed 41-82%, chitosan-g-PEGm 37-41%
and the chitosan-g-PVOH films 35-39% permeability. In the case of chitosan-g-PHEMA
films, all the copolymer films exhibited almost same permeability of 31%. The
permeability of commercial cellulose films studied under similar experimental conditions
was found to be 16% while virgin chitosan films had a value of 37% (Fig 7.5). Hence, it
is established that certain chemical modification through grafting enhanced the creatinine
permeability of chitosan. The PVAc grafted system exhibited comparatively better
performance among the series.
0
10
20
30
40
50
60
70
80
90
% C
reat
inin
e P
erm
eate
d
Cellulo
se
Chitosa
n
CH-HE5
CH-HE7.5
CH-HE12
.5
CH-V4B
CH-V6B
CH-V10
B
CH-V4A
CH-V6A
CH-V10
A
CH-P3
CH-P5
Creatinine
Fig 7.5. The percentage of creatinine permeated at a 24 h study
Fig 7.6 high lights the glucose permeability comparison among the copolymers.
All the copolymer films except the CH-HE5 composition showed better permeability to
glucose than virgin chitosan and cellulose films.
Chapter Chapter Chapter Chapter 7777
241
0
5
10
15
20
25
30
35
40
% G
luco
se P
erm
eate
d
Cellulo
se
Chitosa
n
CH-HE5
CH-HE7.5
CH-HE12
.5
CH-V4B
CH-V6B
CH-V10
B
CH-V4A
CH-V6A
CH-V10
A
CH-P3
CH-P5
Glucose
Fig 7.6. The percentage of glucose permeated at a 24 h study
Fig 7.7 depicts the maximum amount of urea permeated through the copolymer
films for 24 h. The urea permeability through the copolymer films when compared with
chitosan and cellulose films revealed the fact that all except the CH-V6A film are equally
good or better than chitosan and cellulose.
0
5
10
15
20
25
30
35
40
45
50
% U
rea
Per
mea
ted
Cellulo
se
Chitosa
n
CH-HE5
CH-HE7.5
CH-HE12
.5
CH-V4B
CH-V6B
CH-V10
B
CH-V4A
CH-V6A
CH-V10
A
CH-P3
CH-P5
Urea
Fig 7.7. The percentage of urea permeated at a 24 h study
Chapter Chapter Chapter Chapter 7777
242
Fig 7.8 illustrates the albumin permeability of the chitosan-g-vinyl polymer films.
The chitosan-g-PHEMA films CH-HE7.5 and CH-HE12.5 showed 20% and 7.6%
permeability to albumin. Virgin chitosan and cellulose films had 1.8% and 0.45%
permeability respectively while all other chitosan copolymers exhibited albumin
permeability in the range of 0.01 to 1.6%.
0
2
4
6
8
10
12
14
16
18
20
% A
lbu
min
Per
mea
ted
Cellulo
se
Chitosa
n
CH-HE5
CH-HE7.5
CH-HE12
.5
CH-V4B
CH-V6B
CH-V10
B
CH-V4A
CH-V6A
CH-V10
A
CH-P3
CH-P5
Albumin
Fig 7.8. The percentage of albumin permeated at a 24 h study
It is realised that modification of chitosan through graft copolymerisation is an
excellent technique for the designing of blood compatible, cell friendly, mechanically
strong, degradable membranes with superior permeability to low molecular weight
solutes and little leakage of albumin like nutrients. Albumin is one of the useful
substances, the leakage of which if left unchecked, may compromise the nutritional
status of the patient; as a generalization, loss of over about 2–3 g of albumin per
treatment session is considered undesirable [1]. The albumin permeability of the graft
copolymers are found to be well within the desired range. The slight augmented
permeability was shown by the CH-HE7.5 (20%) and CH-HE12.5 (7.6%) compositions
which amount to be 1.6 g and 0.6 g albumin respectively (the concentration of albumin
in the donor cell is 8g/dl) and the permeability of other compositions are highly
Chapter Chapter Chapter Chapter 7777
243
acceptable as they range from 0.8 mg to 130 mg which is significantly very less. On
verification of the permeability of the chitosan-g-vinyl polymers it is obvious that the
chitosan-g-PMMA, chitosan-g-PVAc, and chitosan-g-PVOH copolymer films are equal
to or better than the commercial cellulose films for application as haemodialysis
membranes. For the chitosan-g-PEGm films, the permeability for low molecular weight
solutes was comparatively less initially due to the crystalline phases of PEO grafts that
impede their transport. However, this was a blessing in disguise for preventing absolutely
the transport of high molecular weight solute like albumin.
It can be concluded that modification of chitosan through grafting is an excellent
technique for the designing of blood compatible, cell friendly, mechanically strong,
degradable membranes with superior permeability to low molecular weight solutes and
little leakage of albumin like nutrients.
7.4.2. Chitosan-g-PMMA Microspheres for Controlled Release of Ampicillin
Numerous controlled or sustained delivery systems with chitosan and its
derivatives have been described in the literature. Chandy and Sharma reported that the
release of drugs from chitosan beads at pH 7.4 is very slow and attributed it to an effect
of crystal structure formation of ampicillin within chitosan beads [2]. In oral
administrations, the use of chitosan is restricted by its fast dissolution in the stomach and
limited capacity for controlling the release of drugs [3]. When chitosan was used as a
drug carrier, the reactive functional groups on the polymer matrix were bonded through
the functional groups on the drug. The rate of cleavage of the bond linking the drug to
the matrix controlled the drug release and in some cases, the activity of the drug also [4].
We hypothesize that the availability of functional groups of chitosan to which the drugs
bind can be controlled by chemical modification through grafting. Chitosan molecule
contains a primary amino group at C2 and hydroxyl group at C6 positions, and hence is
amenable for a host of chemical reactions under mild conditions. PMMA is one of the
synthetic materials that is currently being used for controlled drug delivery [5-9]. It was
expected that the modification of chitosan by PMMA could control its fast degradation
Chapter Chapter Chapter Chapter 7777
244
and also to modulate the in vitro release of the encapsulated drug, without sacrificing its
bioactivity. The section 3.2 of chapter 3 details the preparation of chitosan and
chitosan-g-PMMA microspheres, the blood compatibility, cytotoxicity, biodegradability
and the drug absorption and drug release properties and the antibacterial properties of the
drug carrying microspheres.
Microspheres were prepared from aqueous solution of the copolymer using
hexane-paraffin mixture. Particle size was controlled by stirring at 600 rpm at room
temperature. The copolymer microspheres were prepared form a homogeneous blend of
virgin chitosan and chitosan-g-PMMA. The drug (ampicillin) encapsulation, controlled
release of the drug, blood compatibility, cytotoxicity, and biodegradability of the
microspheres were studied in detail. The results promised that the chitosan–g-PMMA are
superior materials for the processing of porous microspheres which serve as excellent
carriers for drug showing controlled release of the incorporated drug for several days
with strong inhibition for both the gram positive and gram negative bacteria in contrast to
virgin chitosan microspheres which showed lesser release and lower anti microbial
properties. Potential applications like oral drug delivery, wound dressings and tissue
engineering are envisaged from these microspheres.
7.5. Conclusions
The objective of the study was to synthesise natural–synthetic hybrid materials
from chitosan and vinyl polymers with tailor made properties depending upon the nature
and concentration of the grafts. The method chosen for the modification was a chemical
route, i.e. graft polymerization of chitosan with the vinyl monomers through a redox
initiation with ceric ammonium nitrate. The objective was achieved through the
copolymerisation of chitosan with the selected vinyl monomers, MMA, HEMA, VAc,
VOH and the methacrylate terminated PEG. The copolymers were found to be strong,
biocompatible and qualified for the proposed end use like haemodialysis membranes and
controlled delivery systems as evident from the data described in preceeding chapters.
Chapter Chapter Chapter Chapter 7777
245
7.6. References
1. Claudio, R., Bernd, B., Sudhir, K. B., Hemodialysis Int., 2006, 10, S48.
2. Chandy, T., Sharma, C. P., Biomaterials, 1993, 14, 12, 939.
3. Remunan-Lopez, Lorenzo-Lamosa, M.L, Vila-Jato, J.L., Alonso, M.J. Eur. J.
Pharm. Biopharm., 1988 Jan, 45, 1, 49.
4. Jayakrishnan, A., Latha, M.S., Biodegradable polymeric microspheres as drug
carriers, in Controlled and novel drug delivery (Ed.), N.K.Jain, CBS
publishers, India, 1997, 236.
5. Calhoun, J. H., Mader, J.T., Am. J. Surg., 1989, 157, 443.
6. Gerhart, T.N., Roux, R. D., Hanff, P. A, Horowitz, G. L., Renshaw, A. A.,
Hayes, W. C. J., Orthop. Res., 1993, Mar; 11, 2, 250.
7. Sivakumar, M., and Rao, K. P., Biomater. Sci. Polym. Edn., 2002, 13, 2, 111.
8. Del Real, R.P., Padilla, S.,Vallet-Regi, M., J. Biomed. Mater. Res., 2000, 52, 1.
9. Yang, J.M., Su, W.Y., Leu, T.L., Yang, M.C., J. Membr. Sci., 2004, 236, 1-2, 39.